Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/22431
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVoulgaris, E.en
dc.contributor.authorPentheroudakis, G.en
dc.contributor.authorVassou, A.en
dc.contributor.authorPavlidis, N.en
dc.date.accessioned2015-11-24T19:24:10Z-
dc.date.available2015-11-24T19:24:10Z-
dc.identifier.issn1872-8332-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/22431-
dc.rightsDefault Licence-
dc.subjectAgeden
dc.subjectAntineoplastic Agents/therapeutic useen
dc.subjectCarcinoma, Non-Small-Cell Lung/*complications/pathology/physiopathologyen
dc.subjectCisplatin/therapeutic useen
dc.subjectDisseminated Intravascular Coagulation/*etiologyen
dc.subjectFatal Outcomeen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectLung Neoplasms/*complications/pathology/physiopathologyen
dc.subjectProtein Kinase Inhibitors/therapeutic useen
dc.subjectQuinazolines/therapeutic useen
dc.subjectThrombocytopenia/etiologyen
dc.titleDisseminated intravascular coagulation (DIC) and non-small cell lung cancer (NSCLC): report of a case and review of the literatureen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1016/j.lungcan.2008.10.027-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/19070399-
heal.identifier.secondaryhttp://ac.els-cdn.com/S0169500208005680/1-s2.0-S0169500208005680-main.pdf?_tid=bd09147b3fbfbb2c5ae2752f6802f89d&acdnat=1333955172_479ee132fa44b0b76337ea0a4c963bc1-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2009-
heal.abstractThe clinical manifestation of disseminated intravascular coagulation (DIC) as paraneoplastic phenomenon is common in patients with lung cancer (especially in those with non small cell lung cancer).Surprisingly, only few data have been published on the prevalence of this phenomenon. Herein we present the case of a patient with metastatic giant-cell carcinoma of the lung complicated by DIC leading the patient to death. We also review the literature regarding the incidence, the pathogenesis and the therapy of DIC in NSCLC. As more effective therapy for lung cancer becomes available and patients live longer, DIC can be expected to be encountered more frequently. Because of this fact clinicians should be alert to the occurrence of such clotting disorders and should be familiar with their diagnosis and management.en
heal.journalNameLung Canceren
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Voulgaris-2009-Disseminated intrava.pdf245.2 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons